Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks

被引:94
|
作者
Murakami, Ryusuke [1 ,2 ]
Matsumura, Noriomi [1 ,2 ,7 ]
Brown, J. B. [3 ,4 ]
Higasa, Koichiro [5 ,6 ]
Tsutsumi, Takanobu [5 ,6 ]
Kamada, Mayumi [3 ]
Abou-Taleb, Hisham [1 ,2 ]
Hosoe, Yuko [1 ,2 ]
Kitamura, Sachiko [1 ,2 ]
Yamaguchi, Ken [1 ,2 ]
Abiko, Kaoru [1 ,2 ]
Hamanishi, Junzo [1 ]
Baba, Tsukasa [1 ,2 ]
Koshiyama, Masafumi [1 ,2 ]
Okuno, Yasushi [3 ]
Yamada, Ryo [5 ,6 ]
Matsuda, Fumihiko [5 ,6 ]
Konishi, Ikuo [1 ,2 ]
Mandai, Masaki [1 ,2 ,7 ]
机构
[1] Kyoto Univ, Dept Gynecol, Kyoto, Japan
[2] Kyoto Univ, Dept Obstet, Kyoto, Japan
[3] Kyoto Univ, Dept Clin Syst Oncoinformat, Kyoto, Japan
[4] Kyoto Univ, Lab Mol Biosci, Kyoto, Japan
[5] Kyoto Univ, Life Sci Informat Res Unit, Grad Sch Med, Kyoto, Japan
[6] Kyoto Univ, Ctr Genom Med, Kyoto, Japan
[7] Kindai Univ, Fac Med, Dept Obstet & Gynecol, Osaka, Japan
关键词
ARID1A MUTATIONS; POOR-PROGNOSIS; CANCER; ENDOMETRIOSIS; CHEMOGENOMICS; INTEGRATION; RESISTANCE; SIGNATURES; TARGETS; BIOLOGY;
D O I
10.1016/j.ajpath.2017.06.012
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Previous studies have reported genome-wide mutation profile analyses in ovarian clear cell carcinomas (OCCCs). This study aims to identify specific novel molecular alterations by combined analyses of somatic mutation and copy number variation. We performed whole exome sequencing of 39 OCCC samples with 16 matching blood tissue samples. Four hundred twenty-six genes had recurrent somatic mutations. Among the 39 samples, ARID1A (62%) and PIK3CA (51%) were frequently mutated, as were genes such as KRAS (10%), PPP2R1A (10%), and PTEN (5%), that have been reported in previous OCCC studies. We also detected mutations in MLL3 (15%), ARID1B (10%), and PIK3R1 (8%), which are associations not previously reported. Gene interaction analysis and functional assessment revealed that mutated genes were clustered into groups pertaining to chromatin remodeling, cell proliferation, DNA repair and cell cycle checkpointing, and cytoskeletal organization. Copy number variation analysis identified frequent amplification in chr8q (64%), chr20q (54%), and chr17q (46%) loci as well as deletion in chr19p (41%), chr13q (28%), chr9q (21%), and chr18q (21%) loci. Integration of the analyses uncovered that frequently mutated or amplified/deleted genes were involved in the KRAS/phosphatidylinositol 3-kinase (82%) and MYC/retinoblastoma (75%) pathways as well as the critical chromatin remodeling complex switch/sucrose nonfermentable (85%). The individual and integrated analyses contribute details about the OCCC genomic landscape, which could lead to enhanced diagnostics and therapeutic options.
引用
收藏
页码:2246 / 2258
页数:13
相关论文
共 13 条
  • [1] Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing
    Kim, Se Ik
    Lee, Ji Won
    Lee, Maria
    Kim, Hee Seung
    Chung, Hyun Hoon
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong-Sang
    Seo, Jeong-Sun
    GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 375 - 382
  • [2] Genomic characterization of Chinese ovarian clear cell carcinoma identification driver genes by whole exome sequencing
    Yang, Qin
    Zhang, Cancan
    Ren, Yuan
    Yi, Huan
    Luo, Tianjiao
    Xing, Fangliang
    Bai, Xuefeng
    Cui, Lining
    Zhu, Linyan
    Ouyang, Jun
    Jiang, Pengcheng
    Fan, Weirong
    Qiu, Jianping
    Wang, Fengmian
    Xing, Xin
    Zhang, Zhigang
    Zhang, Xueli
    Zhang, Rong
    NEOPLASIA, 2020, 22 (09): : 399 - 430
  • [3] Gene set-based integrative analysis of ovarian clear cell carcinoma
    Chang, Chia-Ming
    Chiou, Shih-Hwa
    Yang, Ming-Jie
    Yen, Ming-Shyen
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2016, 55 (04): : 552 - 557
  • [4] Somatic Mutation Profiles of Clear Cell Endometrial Tumors Revealed by Whole Exome and Targeted Gene Sequencing
    Le Gallo, Matthieu
    Rudd, Meghan L.
    Urick, Mary Ellen
    Hansen, Nancy F.
    Zhang, Suiyuan
    Lozy, Fred
    Sgroi, Dennis C.
    Bel, August Vidal
    Matias-Guiu, Xavier
    Broaddus, Russell R.
    Lu, Karen H.
    Levine, Douglas A.
    Mutch, David G.
    Goodfellow, Paul J.
    Salvesen, Helga B.
    Mullikin, James C.
    Bell, Daphne W.
    CANCER, 2017, 123 (17) : 3261 - 3268
  • [5] Common and specific genes in ovarian clear cell carcinoma and serous carcinoma by gene expression analysis
    Cao, Wenjiao
    Wang, Lihua
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (06) : 1501 - 1509
  • [6] Somatic mutation of targeted sequencing identifies risk stratification in advanced ovarian clear cell carcinoma
    Wan, Shimeng
    Gao, Yang
    Wu, Sisi
    Wang, Hua
    Tong, Jiyu
    Wei, Wei
    Ren, Hang
    Yang, Danni
    He, Hao
    Ye, Hong
    Cai, Hongbing
    GYNECOLOGIC ONCOLOGY, 2024, 191 : 56 - 66
  • [7] Differentiation of ovarian serous carcinoma from ovarian clear cell carcinoma using a 10-gene signature selected by comprehensive gene expression analysis
    Nomura, Shinji
    Watanabe, Takafumi
    Honma, Reiko
    Matsukura, Susumu
    Ito, Emi
    Imai, Jun-ichi
    Kiko, Yuichiro
    Suzuki, Osamu
    Hashimoto, Yuko
    Kojima, Manabu
    Furukawa, Shigenori
    Soeda, Shu
    Watanabe, Shinya
    Fujimori, Keiya
    FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2024, 70 (02) : 65 - 73
  • [8] Clinical analysis and literature review of a case of ovarian clear cell carcinoma with PIK3CA gene mutation: A case report
    Farah, Abdulkarim Mohamed
    Gu, Shiyu
    Jia, Yan
    MEDICINE, 2022, 101 (37) : E30666
  • [9] Exploring the cellular and molecular differences between ovarian clear cell carcinoma and high-grade serous carcinoma using single-cell RNA sequencing and GEO gene expression signatures
    Guo, Dan
    Zhang, Sumei
    Gao, Yike
    Shi, Jinghua
    Wang, Xiaoxi
    Zhang, Zixin
    Zhang, Yaran
    Wang, Yuming
    Zhao, Kun
    Li, Mei
    Wang, Anqi
    Wang, Pan
    Gou, Yanqin
    Zhang, Miao
    Liu, Meiyu
    Zhang, Yuhan
    Chen, Rui
    Sun, Jian
    Wang, Shu
    Wu, Xunyao
    Liang, Zhiyong
    Chen, Jie
    Lang, Jinghe
    CELL AND BIOSCIENCE, 2023, 13 (01)
  • [10] Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis
    Wang, Sheng
    Yu, Zhi-hong
    Chai, Ke-qun
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019